C反应蛋白与辅助生殖技术结局:系统综述
该系统综述纳入10项研究,评估胚胎移植前循环CRP浓度与ART妊娠率的关系,并描述早期胚胎着床后血清CRP变化。多数研究报告ART成功者围着床期CRP较高而种植窗前期较低;但研究终点不含活产,CRP预测价值尚需大型前瞻性研究验证。
要点
- ART成功者种植窗前期CRP较低、围着床期CRP较高。
- 孕前高CRP可能对ART结局有不利影响。
- CRP预测价值未证实,需大型前瞻性研究。
核心结论
- 孕前高循环CRP浓度可能对ART结局有不利影响。
- CRP定量可能是ART结局的潜在标志物,但预测价值仍需大型前瞻性研究验证。
研究设计与样本
- 系统综述,检索MEDLINE从建库至2019年3月,仅限英文文章,最终纳入10项研究。
- 方案注册于PROSPERO,注册号CRD148687,由两名评审独立筛选和评估。
主要发现
- 多数研究报告ART成功(生化或临床妊娠)者种植窗前期循环CRP较低、围着床期CRP较高。
- 多种降低循环CRP浓度的生活方式因素和/或药物可显著改善ART结局。
- 建议未来分析按女性BMI和基线循环CRP浓度进行亚组分析。
临床怎么用
- 开始ART前定量循环CRP可能有助于识别ART预后不良的患者。
- 对CRP升高者或可考虑取消ART周期或孕前治疗,以减少医疗风险和费用。
局限性
- 纳入研究的终点为生化或临床妊娠率,无活产结局数据。
- 分析未考虑影响CRP和/或ART的主要变量,如母亲年龄、BMI、移植胚胎数和抗炎药物使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A dynamic balance between pro- and anti-inflammatory factors contributes to regulating human female reproduction. Chronic low-grade inflammation has been detected in several female reproductive conditions, from anovulation to embryo implantation failure. C-reactive protein (CRP) is a reliable marker of inflammation that is extensively used in clinical practice. Recent studies quantified CRP in the serum of infertile women undergoing ART and suggested its potential for the prediction of ART reproductive outcomes. OBJECTIVE AND RATIONALE: The first objective of this systematic review of the available literature was to evaluate the association between pre-implantation circulating CRP concentration and pregnancy rates in women undergoing ART. The second objective was to describe serum CRP concentration changes after early embryo implantation. The changes in circulating CRP throughout the ART cycle, clinical implications of CRP quantification for the management of women undergoing ART, and future therapeutic options will also be discussed. SEARCH METHODS: The MEDLINE database was systematically searched from inception to March 2019 using the following key words: (C-reactive protein) AND (assisted reproductive techniques OR ovulation induction OR insemination OR in vitro fertilization). Only articles in English were considered. Studies were selected based on title and abstract. The full text of potentially relevant articles was retrieved and assessed for inclusion by two reviewers (S.B. and S.H.). The protocol was registered in the International prospective register of systematic reviews (PROSPERO; registration number: CRD148687). OUTCOMES: In total, 10 studies were included in this systematic review. Most of these studies reported lower circulating CRP values before the window of implantation and higher circulating CRP values during the peri-implantation period in women with successful ART outcome (biochemical or clinical pregnancy) compared to women without a successful outcome. Several lifestyle factors and/or drugs that reduce the concentration of circulating CRP significantly improve ART outcomes. Subgroup analyses according to female BMI and baseline circulating CRP concentration are highly recommended in future analyses. WIDER IMPLICATIONS: These findings highlight a possible detrimental impact of preconception high circulating CRP concentration on ART outcomes. However, the biochemical or clinical pregnancy rate endpoints used in the studies examined here are insufficient (there were no data on live birth outcome), and the impact of major variables that can influence CRP and/or ART, for example maternal age, BMI, number of transferred embryos, and use of anti-inflammatory drugs, were not considered in the analyses. CRP quantification may be a potential marker of ART outcome, but its predictive value still needs to be investigated in large prospective studies. In future, the quantification of circulating CRP before starting ART could help to identify patients with a poor ART prognosis, leading to ART cycle cancellation or to preconception treatment to minimize the medical risks and costs.
引用
- Brouillet S, Boursier G, Anav M, et al. C-reactive protein and ART outcomes: a systematic review. Hum Reprod Update. 2020. PMID: 32469070. doi:10.1093/humupd/dmaa012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。